Advanced Search
  • Apr 27, 2012
    Six Month Pooled Outcomes From Randomized and Crossover Patients Following Renal Denervation Presented at the 22nd Annual Scientific Meeting of the European Society of Hypertension Confirm Previous Symplicity Clinical Trial Findings

    MINNEAPOLIS & LONDON, Apr 27, 2012 (BUSINESS WIRE) --Medtronic, Inc., (NYSE: MDT), announced today six month pooled outcomes from randomized and crossover patients in the Symplicity HTN-2 clinical...

  • Apr 24, 2012
    Medical Technology Leader Ranked in Top 50 on Corporate Responsibility Magazine's 100 Best Corporate Citizens List

    MINNEAPOLIS, Apr 24, 2012 (BUSINESS WIRE) --Medtronic, Inc. is one of America's best corporate citizens, according to the rankings recently released by Corporate Responsibility magazine. Medtronic...

  • Apr 17, 2012
    International Research Program Will Collect and Assess Safety and Efficacy Data on IN.PACT Admiral(TM) Drug-Eluting Balloon in Treatment of Peripheral Artery Disease

    MINNEAPOLIS & LONDON, Apr 17, 2012 (BUSINESS WIRE) --In conjunction with the Charing Cross International Symposium (CX34), which concludes today in London, Minneapolis-based Medtronic, Inc. (NYSE:...

  • Apr 16, 2012
    Market-Leading Medical Device for Minimally Invasive Treatment of Abdominal Aortic Aneurysms Continues to Demonstrate Strong Safety and Efficacy

    MINNEAPOLIS & LONDON, Apr 16, 2012 (BUSINESS WIRE) --Bolstering confidence in endovascular repair of abdominal aortic aneurysms (AAA), Medtronic Inc. (NYSE:MDT) announced yesterday the two-year...

  • Apr 16, 2012
    Latest innovation offers power technology for reconstructive spine surgery

    MEMPHIS, Tenn., Apr 16, 2012 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today announced the initiation of its launch of the POWEREASE(TM) System, an innovative system of electronic instruments...